Pacific Biosciences of California Aktie
1,62
EUR
+0,02
EUR
+1,24
%
1,73
USD
+0,09
USD
+5,49
%
Werbung
Pacific Biosciences of California Aktie Analyse
19.10.18 | Pacific Biosciences of California Outperform | Cowen and Company, LLC | |
03.11.16 | Pacific Biosciences of California Buy | Cantor Fitzgerald | |
15.04.16 | Pacific Biosciences of California Overweight | First Analysis Securities | |
04.02.15 | Pacific Biosciences of California Buy | Maxim Group |
Werbung